- Home
- DVA vs JBL Comparison
DVA vs JBL Comparison
Compare DVA & JBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- JBL
- Stock Information
- Founded
- DVA 1994
- JBL 1966
- Country
- DVA United States
- JBL United States
- Employees
- DVA N/A
- JBL N/A
- Industry
- DVA Misc Health and Biotechnology Services
- JBL Electrical Products
- Sector
- DVA Health Care
- JBL Technology
- Exchange
- DVA Nasdaq
- JBL Nasdaq
- Market Cap
- DVA 10.9B
- JBL 19.4B
- IPO Year
- DVA 1995
- JBL 1993
- Fundamental
- Price
- DVA $142.39
- JBL $217.78
- Analyst Decision
- DVA Hold
- JBL Strong Buy
- Analyst Count
- DVA 4
- JBL 7
- Target Price
- DVA $157.00
- JBL $213.57
- AVG Volume (30 Days)
- DVA 818.9K
- JBL 1.9M
- Earning Date
- DVA 08-05-2025
- JBL 06-17-2025
- Dividend Yield
- DVA N/A
- JBL 0.15%
- EPS Growth
- DVA 14.90
- JBL N/A
- EPS
- DVA 10.11
- JBL 5.11
- Revenue
- DVA $12,968,524,000.00
- JBL $28,514,000,000.00
- Revenue This Year
- DVA $6.46
- JBL N/A
- Revenue Next Year
- DVA $3.24
- JBL $4.66
- P/E Ratio
- DVA $14.01
- JBL $42.63
- Revenue Growth
- DVA 5.11
- JBL N/A
- 52 Week Low
- DVA $131.76
- JBL $95.85
- 52 Week High
- DVA $179.60
- JBL $219.00
- Technical
- Relative Strength Index (RSI)
- DVA 56.08
- JBL 89.83
- Support Level
- DVA $135.07
- JBL $202.30
- Resistance Level
- DVA $141.79
- JBL $208.69
- Average True Range (ATR)
- DVA 2.89
- JBL 5.34
- MACD
- DVA 0.67
- JBL 2.91
- Stochastic Oscillator
- DVA 76.82
- JBL 93.48
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About JBL Jabil Inc.
Jabil Inc is a United States-based company engaged in providing manufacturing services and solutions. It provides comprehensive electronics design, production and product management services to companies in various industries and end markets.The Company derives its revenue from providing comprehensive electronics design, production and product management services. It operates in two segments. The Electronics Manufacturing Services (EMS) segment, which is the key revenue driver, is focused on leveraging IT, supply chain design and engineering, technologies largely centered on core electronics. The Diversified Manufacturing Services (DMS) segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies, and healthcare.